Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02268474 · ClinicalTrials.gov registry record · NA
Excel V 532 nm KTP Laser for Treatment of Erythematotelangiectatic Rosacea & Papulopustular Rosacea
A NA study of Papulopustular Rosacea and Erythematotelangiectatic Rosacea, sponsored by Cutera.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT02268474: Completed NA study of Papulopustular Rosacea and Erythematotelangiectatic Rosacea, sponsored by Cutera.
NCT02268474 is a NA study of Papulopustular Rosacea and Erythematotelangiectatic Rosacea that has completed, run by Cutera. The registered enrollment target is 22 participants, below the 277-participant average among 11 other Papulopustular Rosacea trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02268474, a NA study of Papulopustular Rosacea and Erythematotelangiectatic Rosacea, has completed, sponsored by Cutera.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
A single center prospective, randomized, controlled split face study comparing a 532nm KTP laser with a 595nm PDL for the treatment of Erythematotelangiectatic Rosacea and Papulopustular Rosacea. Subjects will receive laser treatments and will be followed at 6 weeks post-final laser treatment.
Primary Outcome
Measured for each treatment arm based on blinded physician assessment of subject photographs using the Physician's Global Assessment Scale (min=0; max=4) Higher scores mean better improvement 0 = 0% Improvement (None) 1. = \< 25% Improvement (Mild) 2. = 26 to 50% Improvement (Moderate) 3. = 51 to 75% Improvement (Significant) 4. = 76 to 100% Improvement (Very Significant)
Conditions Studied
Interventions
- DEVICE 532nm KTP Laser vs 595nm Pulse Dye Laser
Study Locations (1)
Florida
- Miami Dermatology & Laser Institute - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-08 |
| Phase | NA |
What the finished NCT02268474 record still lists
NCT02268474 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 277-participant average among 11 other Papulopustular Rosacea trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Papulopustular Rosacea appearing as the primary indexed condition, and to 1 intervention - of which 532nm KTP Laser vs 595nm Pulse Dye Laser is the first listed.
NCT02268474 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02268474 about?
NCT02268474 is a clinical study titled "Excel V 532 nm KTP Laser for Treatment of Erythematotelangiectatic Rosacea & Papulopustular Rosacea". A single center prospective, randomized, controlled split face study comparing a 532nm KTP laser with a 595nm PDL for the treatment of Erythematotelangiectatic Rosacea and Papulopustular Rosacea. Subjects will receive laser treatments and will be followed at 6 weeks post-final laser treatment.
What is the current status of trial NCT02268474?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2014-09. Estimated completion is 2015-08.
What conditions does trial NCT02268474 study?
This clinical trial studies the following conditions: Papulopustular Rosacea, Erythematotelangiectatic Rosacea.
What interventions are being tested in trial NCT02268474?
The interventions under investigation include: 532nm KTP Laser vs 595nm Pulse Dye Laser (DEVICE).
Who is sponsoring clinical trial NCT02268474?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02268474 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Papulopustular Rosacea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02268474's enrollment target sits among peer trials
22 10th of 11 higher than 2 of 11 other Papulopustular Rosacea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Papulopustular Rosacea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea
RECRUITING · Phase 2
-
Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical Properties
COMPLETED · Phase 1
-
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
COMPLETED · Phase 3
-
Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea
COMPLETED · Phase 4
-
A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.
COMPLETED · Phase 3
-
A Twelve Week Safety and Efficacy Study in Rosacea
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia